期刊文献+

心房纤颤住院患者320例临床分析 被引量:4

Clinical Anaylsis for the Atrial Fibrillation 320 Inpatients
暂未订购
导出
摘要 目的分析心房纤颤住院患者的病因、临床特点和治疗现状。方法对湖南省衡阳冶金医院2006年1月—2009年12月320例心房纤颤患者的临床资料进行回顾性分析。结果心房纤颤患者中阵发性、持续性和永久性心房纤颤各占10.9%、4.8%、84.3%。高血压是最常见的病因(37.33%)、其次是冠心病(34.12%)、风湿性心瓣膜病(17.1%)。永久性心房纤颤患者46.21%心功能Ⅲ~Ⅳ级,与阵发性心房纤颤相比有较大的左房内径〔(45.36±8.34)mm:(32.96±6.54)mm,P<0.05〕和较低的射血分数〔(56.40±10.98)%:(63.36±10.23)%,P<0.05〕。心房纤颤患者血栓栓塞事件发生率为6.8%,其中风湿性心房纤颤为非风湿性心房纤颤的4.68倍。心房纤颤患者华法令应用率仅为10%。结论血栓栓塞是心房纤颤的重要并发症。心房纤颤和慢性心力衰竭互为危险因素,两者常常合并发生。 Objective To analysze the underlying diseases, the clinical charaeterisyics and the treatment of artial fibiriltation (AF) inpatients. Methods 320inpatients artial fibrillation were selected during 2006 Jananry and 2009 December in Hunan province Hengyang Yejin hospital retrospectively their clinical data. Resolts The relative prevalenees of paroxysmal, permanent, and persistent AF were 10. 9% , 408%, and84.3%. The first disease factor was hypertension ( 37. 33% ), the second factor was coronary heart disease (34. 12% ) , the third factor was rheumatic heart disease ( 17.1% ). The persistent AF (46. 12% ) were in class Ⅲ - Ⅳ of NYHA Compared with the paroxysmal AF, the persistent group had a significantly larger left atrial diameter ( (45.36 ±8.34) mm vs (32.96±6.54) ram, P 〈0. 053 and lower ejection fraction [ (56.40 ± 10. 98) vs (63. 36±10. 23)%, P 〈0. 05 ) . Aprior thromboembolic event occurred in 22 inpatients (6. 8% ). Rheumatic AF embolism rate was nonrheumatic AF 4.68.32 inpatients ( 10% ) received warfarin. Conclusion Embolism is very important eompolieations of AF. AF and chronic heart failure are risk factor each other. They often consolidate.
出处 《实用心脑肺血管病杂志》 2011年第1期94-95,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 心房纤颤 栓塞 抗凝 心功能 Atrial fibrillation Embolism Anticoagulant Heart function
  • 相关文献

参考文献7

  • 1郭继鸿.心房颤动药物治疗的10个临床问题[J].中国实用内科杂志,2008,28(6):422-425. 被引量:38
  • 2李铁军,孙英贤.心房颤动的治疗方法选择[J].中国实用内科杂志,2008,28(6):419-422. 被引量:33
  • 3Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of artial fibrillation in general practice in France: the ALFA study [J]. Circulation, 1999, 99:3028-3035.
  • 4Igarashi Y, Kasaiah, Yamashita F, et al. Lipoprotein (a), left atrial appendage function and thromboemboembolic risk in pastsient chronic non-valular atrial fibrillation [J]. Jpn Circ J, 2000, 64:93-98.
  • 5叶任高,陆再英.内科学[M].6版.北京:人民卫生出版社,2005.948-987.
  • 6Wolf PA, Abbott RD, Kannal WB, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham study [ J]. Stroke, 1990, 131:983-988.
  • 7曾敏,吴智勇,郑茵,陈娟,冯光球,符秀虹.不同年龄段非瓣膜病心房纤颤的临床特点与预后分析[J].中国全科医学,2010,13(7):790-791. 被引量:6

二级参考文献7

  • 1Friberg L, Hammar N, Rosenqvlst M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation [ J ].Eur Heart J, 2009, 27: Epub ahead of print.
  • 2Ferro D, Loffredo L, Polimeni L, et al. Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy [ J ]. Intern Emerg Med, 2007, 2:24 -28.
  • 3Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham study [ J] . Arch InternMed, 1987, 47:1561-1564.
  • 4Stroke risk in atrial fibrillation working group. Independent predictors of stroke in patients with atrial fibrillation: a systematie review [J]. Neurology, 2007, 69 (6): 546-54.
  • 5Tedesco MA, Di Salvo G, Ratti G, et al. Left atrial size in 164 hypertensive patients: an eeh- oeardiographic and ambulatory blood pressure study [J] . Chin Cardiol, 2001, 24:603 - 607.
  • 6Watraven C, Hart RG, Connolly S, et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators [J] . Stroke, 2009, 40 (4) : 1410 - 1406.
  • 7任常陵,井上埔.心房纤颤的治疗——最新进展、栓塞症的预知和预防[J].日本医学介绍,2002,23(10):465-466. 被引量:2

共引文献400

同被引文献18

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1408
  • 2胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:163
  • 3曹克将,陈明龙.加强心房颤动的综合治疗[J].中华心血管病杂志,2006,34(8):766-768. 被引量:38
  • 4心房颤动抗栓研究协作组,胡大一,孙艺红,张鹤萍,姜立清.华法林对非瓣膜病心房颤动抗栓的安全性和有效性研究[J].中华内科杂志,2006,45(10):800-803. 被引量:64
  • 5Steinberg JS. Atrial fibrillation:an emerging epidemic[ J] . Heart,2004,90(3) :239 -240.
  • 6Kannel WB,Benjamin EJ. Status of the epidemionlogy of atril fi-brillation [J], Med Clin North Am,2008 ,92( 1) ; 17 -40.
  • 7Spach MS. Mounting evadence that fibrosis generates a major mecha-nism for atrial fibrillation [ J]. Circ Res, 2007,101 ( 8 ) : 743 -745.
  • 8Investigators A, Connolly S J, Pogue J, et al.Effect of clopidogrel added to aspirin in patients with atrial fibrillation[J].N Engl J Med, 2009, 360(20): 2066-2078.
  • 9Laupacis A, Boysen G, Connolly S, et al.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.Analysis of pooled data from five randomized controlled trials[J].Areh Intern Med, 1994, 154(13): 1449-1457.
  • 10Hill M N, Miller N H, Degeest S, et al.Adherence and persistence with taking medication to control high blood pressure[J].J Am Soc Hypertens, 2011, 5(1): 56-63.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部